Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1991 1
1998 1
2000 1
2001 2
2002 3
2003 3
2004 1
2005 2
2006 8
2007 5
2008 3
2009 6
2010 13
2011 17
2012 10
2013 16
2014 6
2015 5
2016 5
2017 7
2018 10
2019 5
2020 5
2021 13
2022 9
2023 7
2024 4
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

149 results

Results by year

Filters applied: . Clear all
Page 1
Inhaled mRNA therapy for treatment of cystic fibrosis: Interim results of a randomized, double-blind, placebo-controlled phase 1/2 clinical study.
Rowe SM, Zuckerman JB, Dorgan D, Lascano J, McCoy K, Jain M, Schechter MS, Lommatzsch S, Indihar V, Lechtzin N, McBennett K, Callison C, Brown C, Liou TG, MacDonald KD, Nasr SZ, Bodie S, Vaughn M, Meltzer EB, Barbier AJ. Rowe SM, et al. Among authors: lechtzin n. J Cyst Fibros. 2023 Jul;22(4):656-664. doi: 10.1016/j.jcf.2023.04.008. Epub 2023 Apr 29. J Cyst Fibros. 2023. PMID: 37121795 Free PMC article. Clinical Trial.
Long-Term Mechanical Ventilation.
Sahetya S, Allgood S, Gay PC, Lechtzin N. Sahetya S, et al. Among authors: lechtzin n. Clin Chest Med. 2016 Dec;37(4):753-763. doi: 10.1016/j.ccm.2016.07.014. Epub 2016 Oct 14. Clin Chest Med. 2016. PMID: 27842754 Free PMC article. Review.
Airway inflammation accelerates pulmonary exacerbations in cystic fibrosis.
Liou TG, Argel N, Asfour F, Brown PS, Chatfield BA, Cox DR, Daines CL, Durham D, Francis JA, Glover B, Helms M, Heynekamp T, Hoidal JR, Jensen JL, Kartsonaki C, Keogh R, Kopecky CM, Lechtzin N, Li Y, Lysinger J, Molina O, Nakamura C, Packer KA, Paine R 3rd, Poch KR, Quittner AL, Radford P, Redway AJ, Sagel SD, Szczesniak RD, Sprandel S, Taylor-Cousar JL, Vroom JB, Yoshikawa R, Clancy JP, Elborn JS, Olivier KN, Adler FR. Liou TG, et al. Among authors: lechtzin n. iScience. 2024 Jan 9;27(3):108835. doi: 10.1016/j.isci.2024.108835. eCollection 2024 Mar 15. iScience. 2024. PMID: 38384849 Free PMC article.
CF: There's an app for that!
Nasr SZ, Lechtzin N. Nasr SZ, et al. Among authors: lechtzin n. J Cyst Fibros. 2020 Mar;19(2):172-173. doi: 10.1016/j.jcf.2020.02.005. Epub 2020 Feb 20. J Cyst Fibros. 2020. PMID: 32089516 Free article. No abstract available.
The PROSPECT Is Bright for CFTR Modulators.
Montemayor K, Lechtzin N. Montemayor K, et al. Among authors: lechtzin n. Ann Am Thorac Soc. 2021 Jan;18(1):32-33. doi: 10.1513/AnnalsATS.202007-881ED. Ann Am Thorac Soc. 2021. PMID: 33385230 Free PMC article. No abstract available.
ALSUntangled No. 30: methylcobalamin.
ALSUntangled Group. ALSUntangled Group. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16(7-8):536-9. doi: 10.3109/21678421.2015.1070574. Epub 2015 Jul 23. Amyotroph Lateral Scler Frontotemporal Degener. 2015. PMID: 26203660 Review. No abstract available.
ALSUntangled No. 16: cannabis.
ALSUntangled Group. ALSUntangled Group. Amyotroph Lateral Scler. 2012 Jun;13(4):400-4. doi: 10.3109/17482968.2012.687264. Amyotroph Lateral Scler. 2012. PMID: 22632446 Review. No abstract available.
ALSUntangled No. 22: Propofol.
ALSUntangled Group. ALSUntangled Group. Amyotroph Lateral Scler Frontotemporal Degener. 2013 Dec;14(7-8):640-2. doi: 10.3109/21678421.2013.826469. Epub 2013 Aug 23. Amyotroph Lateral Scler Frontotemporal Degener. 2013. PMID: 23971884 Review. No abstract available.
Telemedicine and remote monitoring in cystic fibrosis.
Edmondson C, Lechtzin N. Edmondson C, et al. Among authors: lechtzin n. Curr Opin Pulm Med. 2023 Jul 1;29(4):277-284. doi: 10.1097/MCP.0000000000000968. Epub 2023 May 9. Curr Opin Pulm Med. 2023. PMID: 37158652 Review.
COURAGE-ALS: a randomized, double-blind phase 3 study designed to improve participant experience and increase the probability of success.
Shefner JM, Al-Chalabi A, Andrews JA, Chio A, De Carvalho M, Cockroft BM, Corcia P, Couratier P, Cudkowicz ME, Genge A, Hardiman O, Heiman-Patterson T, Henderson RD, Ingre C, Jackson CE, Johnston W, Lechtzin N, Ludolph A, Maragakis NJ, Miller TM, Mora Pardina JS, Petri S, Simmons Z, Van Den Berg LH, Zinman L, Kupfer S, Malik FI, Meng L, Simkins TJ, Wei J, Wolff AA, Rudnicki SA. Shefner JM, et al. Among authors: lechtzin n. Amyotroph Lateral Scler Frontotemporal Degener. 2023 Aug;24(5-6):523-534. doi: 10.1080/21678421.2023.2216223. Epub 2023 May 30. Amyotroph Lateral Scler Frontotemporal Degener. 2023. PMID: 37254449 Free article. Clinical Trial.
149 results